Drug FDA Class II Ongoing Sub/super-potent
Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Viatris Inc Published Dec 18, 2024
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Viatris Inc or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Superpotent Drug and Subpotent Drug: potency failures obtained
Hazards
Superpotency and Subpotency · primary
Affected products (1)
Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
LEVOTHYROXINE SODIUM · 34,845 bottes
NDC: 0378-1800, 0378-1803, 0378-1805, 0378-1807, 0378-1809, 0378-1811, 0378-1813, 0378-1823, 0378-1815, 0378-1817, 0378-1819, 0378-1821, 0378-1800-77, 0378-1800-10, 0378-1803-77, 0378-1803-10, 0378-1805-77, 0378-1805-10, 0378-1807-77, 0378-1807-10, 0378-1809-77, 0378-1809-10, 0378-1811-77, 0378-1811-10, 0378-1813-77, 0378-1813-10, 0378-1823-77, 0378-1823-10, 0378-1815-77, 0378-1815-10, 0378-1817-77, 0378-1817-10, 0378-1819-77, 0378-1819-10, 0378-1821-77
Code info: Lot #: a) 8181875, Exp. Date Aug 2025; 8174497, Exp. Date April 2025 b) 3209099, Exp. Date Sep 2025; 3206534, Exp. Date Aug 2025; 3196137, Exp. Date April 2025
Affected areas
Nationwide
Timeline
- InitiatedNov 18, 2024
- PublishedDec 18, 2024
- Recall number
- D-0123-2025
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.